Accessibility helpSkip to navigationSkip to contentSkip to footer

Cookies on FT Sites

We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.

Accept cookies
Manage cookies
  • Sign In
  • Subscribe
Open side navigation menuOpen search bar
Financial Times
SubscribeSign InmyFT
  • Home
  • World
    Sections
    • World Home
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    • Australia & NZ
    Most Read
    • Joe Biden raised Canadian Sikh’s death with India’s Narendra Modi at G20
    • The decoy weapons leading Russian forces astray in Ukraine
    • F-35 fighter jets can only fly 55% of time, US watchdog says
    • Russian state TV promotes new Tucker Carlson show
    • US senator Robert Menendez indicted on federal bribery charges
  • UK
    Sections
    • UK Home
    • UK Economy
    • UK Politics
    • Brexit
    • UK Companies
    • Personal Finance
    Most Read
    • Jeremy Hunt plans Isa overhaul to boost share ownership
    • Rishi Sunak plans to overhaul A-level system with ‘British baccalaureate’
    • UK recession risk increases as services activity falls
    • UK mortgage rates set to fall after Bank of England knife-edge vote
    • Number of UK nursing students plummets despite NHS shortages
  • Companies
    Sections
    • Companies Home
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
    Most Read
    • Asahi chief warns climate change could lead to beer shortages
    • Rupert Murdoch resolves his own succession drama — for now
    • Crispin Odey faces first lawsuit over alleged sexual misconduct
    • US auto strike expands to 38 General Motors and Stellantis facilities
    • Silchester-backed asset management boutique shuts its doors
  • Tech
  • Markets
    Sections
    • Markets Home
    • Alphaville
    • Markets Data
    • Cryptofinance
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Fund Management
    • Trading
    • Moral Money
    • ETF Hub
    Most Read
    • News updates from September 22: US senator Menendez indicted, Bank of Japan maintains ultra-low rates
    • Jeremy Hunt plans Isa overhaul to boost share ownership
    • How Xi Jinping is taking control of China’s stock market
    • Monzo clients rush to sign up for BlackRock offering
    • Russia puts squeeze on oil market with diesel export ban
  • Climate
  • Opinion
    Sections
    • Opinion Home
    • Columnists
    • The FT View
    • Lex
    • Obituaries
    • Letters
    Most Read
    • Russell Brand learnt his tricks in television studios
    • How to save your state pension
    • Are we destined for a zero-sum future?
    • Lachlan’s accession won’t put an end to Murdoch family strife
    • Populism could derail the green transition
  • Work & Careers
    Sections
    • Work & Careers Home
    • Business School Rankings
    • Business Education
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
    Most Read
    • ‘There is no work to balance’: how shrinking budgets, Covid and AI shook up life in consulting
    • American Express’s Steve Squeri: ‘If you’re not ready for the upswing, you’ve missed’
    • FT Business Books — what to read this month
    • Can I start a business when I have MS?
    • The plight of the hidden carers in your workforce
  • Life & Arts
    Sections
    • Life & Arts Home
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
    Most Read
    • Anna Wintour: ‘I just have to make sure things are being done right’
    • Who’d invite the boss to dinner?
    • John Fetterman, dress codes and American anarchy
    • PowerPoint is widely reviled. How did it triumph?
    • Bosses won’t like it but WFH is a happier way to work
  • HTSI
MenuSearch
  • Home
  • World
  • UK
  • Companies
  • Tech
  • Markets
  • Climate
  • Opinion
  • Work & Careers
  • Life & Arts
  • HTSI
Financial Times
SubscribeSign In

US opioid epidemic

Add to myFT Digest

Add this topic to your myFT Digest for news straight to your inbox

  • Monday, 18 September, 2023
    OutlookPatti Waldmeir
    Tactics are shifting in the war on drugs

    Experimentation continues on measures to tackle addiction and fatal overdoses

    A box containing naloxone overdose emergency kits outside a store at Canal Park in Pennsylvania
  • Wednesday, 23 August, 2023
    Lex
    Mallinckrodt: legal rejig may slash $1.1bn from opioid victims’ trust Premium content

    Drug producer’s prospects are poor enough that its reset enterprise value is just $3bn

    Homeless people are seen on streets of  Kensington, Philadelphia
  • Friday, 11 August, 2023
    ReviewTelevision
    Painkiller is a surprisingly watchable drama about the opioid crisis

    The new six-part Netflix series is a comprehensive and pacy examination of mass greed and its consequences

    A man with grey hair and a grey suit stands outside a grand building in front of a microphone as it snows, two men in black suits flanking him.
  • Thursday, 10 August, 2023
    Purdue Pharma LP
    Supreme Court halts $6bn Purdue opioid settlement in blow to Sacklers

    Justices will consider whether the law permits the waiver of future claims against parties not in bankruptcy

    A pharmacist holds a bottle of OxyContin
  • Monday, 12 June, 2023
    Inside BusinessSujeet Indap
    Opioid victims fear the pain of junior creditor status at Mallinckrodt

    Payouts at risk of falling below other creditors in any repeat bankruptcy

    30mg pills of the painkiller Oxycodone Hydrochloride
  • Wednesday, 31 May, 2023
    News in-depth
    ‘People rot from the inside out’: lethal xylazine deepens the US drug crisis

    Cartels are cutting fentanyl with the cheap sedative, driving a surge in overdoses in cities such as Philadelphia

    A nurse practitioner treats wounds on a patient
  • Tuesday, 30 May, 2023
    Purdue Pharma allowed to shield Sackler owners from opioid lawsuits

    Appeals court says some liability releases are ‘appropriate’ under US bankruptcy law

    A bottle of OxyContin made by Purdue Pharma
  • Friday, 26 May, 2023
    Cryptofinance
    Crypto’s dark role in the US opioid epidemic

    Plus, losses to crypto fraud rises and update on Do Kwon

    An image of a fentanyl syringe
  • Thursday, 18 May, 2023
    FT Magazine
    What if San Francisco never pulls out of its ‘doom loop’?

    A crisis of homelessness, drug abuse and sensationalised crime threaten the city’s future

  • Tuesday, 16 May, 2023
    University of Oxford
    Oxford university drops Sackler name from buildings after investigation

    Decision comes at end of review instigated by new vice-chancellor Irene Tracey

    A view of the Radcliffe Camera building, part of the Bodleian Library, in Oxford
  • Tuesday, 4 April, 2023
    Mexico
    Mexico’s president seeks help from China’s Xi on deadly fentanyl imports

    Plea from Andrés Manuel López Obrador follows pressure from US lawmakers over trafficking of drug across border

    Andrés Manuel López Obrador speaks to media
  • Sunday, 12 March, 2023
    News in-depthMexico
    US turns up heat on Mexico after cartel kidnappings

    Deaths of US citizens and steeply rising fentanyl casualties prompt rising frustration in Washington

    State police keep watch at the scene where authorities found the bodies of two of four Americans kidnapped by gunmen, in Matamoros, Mexico
  • Monday, 20 February, 2023
    News in-depthFT Investigations
    Oxford university stuck with Sacklers as opioid deaths led others to cut ties

    Documents show privileged access to the Boat Race and continued acceptance of donations

    Dame Theresa Sackler
  • Sunday, 22 January, 2023
    US warns overdose crisis will spread overseas without action from China

    White House drugs tsar says Beijing needs to tighten rules on supply of raw materials to make fentanyl

    Evidence seized after a traffic stop led officers to major methamphetamine and fentanyl trafficking operation in California
  • Thursday, 19 January, 2023
    The Oscars 2023: all you need to know
    Laura Poitras on Nan Goldin and their film taking on the opioid crisis

    The director discusses the fight to expose the Sackler family’s ‘artwashing’ of a fortune built on addictive drugs

    A photo-portrait of Laura Poitras
  • Thursday, 29 December, 2022
    AmerisourceBergen slapped with federal lawsuit over opioids crisis

    Drug distributor knew pills were likely being sold in parking lots for cash, allege prosecutors

    A logo sign outside of a facility occupied by  AmerisourceBergen in Corona, California
  • Tuesday, 15 November, 2022
    Walmart Inc
    Walmart lifts guidance as richer consumers go bargain hunting

    Retailer upgrades outlook even as $3.1bn opioids settlement results in quarterly net loss

    Walmart signage outside a store
  • Tuesday, 8 November, 2022
    US to boost medication access to tackle opioid overdose crisis

    Legal, societal and financial barriers block treatments that can reduce risk of overdose

    AA buprenorphine bottle in front of a wall commemorating those who were killed by fentanyl overdoses in 2022
  • Wednesday, 2 November, 2022
    US pharmacy groups CVS and Walgreens agree $10bn opioid settlements

    Other chains also in talks over claims linked to their roles in crisis

    A CVS store in Manhattan
  • Thursday, 8 September, 2022
    Edward Luce
    America’s indifference to its death crisis

    The enduring drivers of the country’s morbid trajectory — rising obesity, the opioid epidemic and Covid — are hard to confront

  • Monday, 5 September, 2022
    Venice Film Festival 2022
    Five stars for opioid epidemic documentary All the Beauty and the Bloodshed

    Laura Poitras’s film is both a biography of artist Nan Goldin and an indictment of the Sackler family

    A pale woman with red hair and glasses looks at the camera as another woman looks into a bathroom mirror
  • Friday, 26 August, 2022
    Data PointsJohn Burn-Murdoch
    How US life expectancy fell off a cliff

    One factor explains why a gulf has opened between America and its wealthy peers: deaths from drug overdoses

    A woman weeps among cardboard gravestones with the details of people who have died of opioid overdoses
  • Wednesday, 15 June, 2022
    InterviewOffice of National Drug Control Policy
    US pivots to ‘harm reduction’ after 107,000 overdose deaths last year

    White House drug tsar says marijuana legalisation and safe injection sites will also be reviewed

    Director of the Office of National Drug Control Policy Rahul Gupta speaks to the media before the offload of approximately $1.06bn in cocaine and marijuana at the Port Everglades in Fort Lauderdale, Florida, on February 17 2022
  • Wednesday, 27 April, 2022
    Pharmaceuticals sector
    McKinsey rebuts conflict claims over work for health regulator and opioid makers

    Congressional probe found 22 consultants had advised both the US FDA and drug manufacturers over a decade

    Bob Sternfels testifies remotely at a House Oversight and Reform committee hearing
  • Thursday, 3 March, 2022
    Purdue Pharma LP
    Purdue and US states agree new $6bn settlement for opioid litigation

    Members of Sackler family who owned OxyContin maker will increase financial contribution but still receive a legal shield

Previous page You are on page 1 Next page

Useful links

Support

View Site TipsHelp CentreContact UsAbout UsAccessibilitymyFT TourCareers

Legal & Privacy

Terms & ConditionsPrivacy PolicyCookiesCopyrightSlavery Statement & Policies

Services

Share News Tips SecurelyIndividual SubscriptionsProfessional SubscriptionsRepublishingExecutive Job SearchAdvertise with the FTFollow the FT on XFT ChannelsFT Schools

Tools

PortfolioToday’s Newspaper (FT Digital Edition)Alerts HubBusiness School RankingsEnterprise ToolsNews feedNewslettersCurrency Converter

Community & Events

FT CommunityFT Live EventsFT ForumsFT Board DirectorBoard Director Programme

More from the FT Group

Markets data delayed by at least 15 minutes. © THE FINANCIAL TIMES LTD 2023. FT and ‘Financial Times’ are trademarks of The Financial Times Ltd.
The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
Financial Times

UK Edition

Subscribe for full access
  • Switch to International Edition

Top sections

  • Home
  • World
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    • Australia & NZ
  • UK
    • UK Economy
    • UK Politics
    • Brexit
    • UK Companies
    • Personal Finance
  • Companies
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
  • Tech
  • Markets
    • Alphaville
    • Markets Data
    • Cryptofinance
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Fund Management
    • Trading
    • Moral Money
    • ETF Hub
  • Climate
  • Opinion
    • Columnists
    • The FT View
    • Lex
    • Obituaries
    • Letters
  • Work & Careers
    • Business School Rankings
    • Business Education
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
  • Life & Arts
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
  • Personal Finance
    • Property & Mortgages
    • Investments
    • Pensions
    • Tax
    • Banking & Savings
    • Advice & Comment
    • Next Act
  • HTSI
  • Special Reports

FT recommends

  • Lex
  • Alphaville
  • Lunch with the FT
  • FT Globetrotter
  • #techAsia
  • Moral Money
  • Visual and data journalism
  • Newsletters
  • Video
  • Podcasts
  • News feed
  • FT Live Events
  • FT Forums
  • Board Director Programme
  • myFT
  • Portfolio
  • Today’s Newspaper (FT Digital Edition)
  • Crossword
  • Our Apps
  • Help Centre
  • Subscribe
  • Sign In